Thomas Arendt

Author PubWeight™ 90.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional patterns of gene expression in human and chimpanzee brains. Genome Res 2004 3.84
2 A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 2009 3.63
3 The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2010 2.23
4 Tissue transglutaminase is not a biochemical marker for Alzheimer's disease. Neurobiol Aging 2013 2.00
5 Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 2004 1.72
6 Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci 2007 1.52
7 Impact of cellular senescence signature on ageing research. Ageing Res Rev 2010 1.47
8 Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis 2002 1.34
9 Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 2004 1.14
10 Structural correlates of mild cognitive impairment. Neurobiol Aging 2004 1.09
11 Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. Brain Res 2006 1.08
12 Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 2002 1.08
13 Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol 2002 1.07
14 Tau gene (MAPT) sequence variation among primates. Gene 2004 1.06
15 Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging 2006 1.05
16 AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 2002 1.05
17 Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004 1.03
18 Tau oligomers impair artificial membrane integrity and cellular viability. J Biol Chem 2012 1.03
19 Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur J Neurosci 2007 1.02
20 Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis 2012 1.01
21 Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol 2012 0.99
22 Systematic analysis of gene expression in human brains before and after death. Genome Biol 2005 0.98
23 Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis 2004 0.96
24 Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci 2005 0.94
25 Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus 2007 0.94
26 Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm (Vienna) 2011 0.94
27 Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem 2006 0.92
28 The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS One 2011 0.91
29 Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int J Dev Neurosci 2005 0.91
30 Complementary distribution of vesicular glutamate transporters 1 and 2 in the nucleus accumbens of rat: Relationship to calretinin-containing extrinsic innervation and calbindin-immunoreactive neurons. J Comp Neurol 2003 0.90
31 Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol 2012 0.90
32 Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res 2006 0.90
33 A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur J Neurosci 2009 0.89
34 Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation 2005 0.89
35 Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol 2002 0.88
36 Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks. Alzheimer Dis Assoc Disord 2002 0.87
37 Cyclin C expression is involved in the pathogenesis of Alzheimer's disease. Neurobiol Aging 2003 0.86
38 The expression of wild-type human amyloid precursor protein affects the dendritic phenotype of neocortical pyramidal neurons in transgenic mice. Int J Dev Neurosci 2005 0.86
39 Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 2005 0.86
40 Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res 2003 0.86
41 Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging 2005 0.85
42 Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. Acta Neuropathol 2003 0.85
43 Pattern of tau isoforms expression during development in vivo. Int J Dev Neurosci 2009 0.85
44 Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur J Neurosci 2006 0.85
45 Smad2 isoforms are differentially expressed during mouse brain development and aging. Int J Dev Neurosci 2009 0.85
46 Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. Cereb Cortex 2006 0.84
47 Changes in neuronal DNA content variation in the human brain during aging. Aging Cell 2012 0.84
48 The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2005 0.84
49 Degeneration of cholinergic rat basal forebrain neurons after experimental subarachnoid hemorrhage. Neurosurgery 2008 0.84
50 Early neurone loss in Alzheimer's disease: cortical or subcortical? Acta Neuropathol Commun 2015 0.83
51 The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res 2005 0.83
52 Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus. Hippocampus 2010 0.83
53 Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease. Acta Neuropathol 2010 0.83
54 The relationship between head size and intracranial volume in elderly subjects. Brain Res 2003 0.83
55 The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis. Exp Gerontol 2006 0.82
56 Constitutive Ras activity induces hippocampal hypertrophy and remodeling of pyramidal neurons in synRas mice. J Neurosci Res 2004 0.82
57 Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease. Neuroreport 2002 0.81
58 Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol 2003 0.81
59 Enhanced Ras activity in pyramidal neurons induces cellular hypertrophy and changes in afferent and intrinsic connectivity in synRas mice. Int J Dev Neurosci 2004 0.81
60 Enhanced Ras activity promotes spine formation in synRas mice neocortex. Neuroreport 2005 0.81
61 Expression of the embryonal isoform (0N/3R) of the microtubule-associated protein tau in the adult rat central nervous system. J Comp Neurol 2010 0.80
62 Laser scanning cytometry in human brain slices. Cytometry A 2006 0.80
63 Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease. Neurobiol Aging 2010 0.80
64 Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Neurobiol Aging 2008 0.80
65 Constitutive expression of p21H-ras(Val12) in pyramidal neurons results in reorganization of mouse neocortical afferents. J Neurobiol 2004 0.80
66 Adaptive morphological changes of neocortical interneurons in response to enlarged and more complex pyramidal cells in p21H-Ras(Val12) transgenic mice. Brain Res Bull 2004 0.78
67 Effects of wild-type and mutant human amyloid precursor protein on cortical afferent network. Neuroreport 2007 0.78
68 Differentially expressed cortical genes contribute to perivascular deposition in transgenic mice with inducible neuron-specific expression of TGF-beta1. Int J Dev Neurosci 2005 0.78
69 Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicol In Vitro 2007 0.78
70 FAD-mutation of APP is associated with a loss of its synaptotrophic activity. Neurobiol Dis 2009 0.78
71 Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells. Neurotox Res 2006 0.78
72 Vesicular glutamate transporter 3-immunoreactive pericellular baskets ensheath a distinct population of neurons in the lateral septum. J Chem Neuroanat 2008 0.78
73 Immunocytochemical evidence for the striatal nature of the rat lateral part of interstitial nucleus of the posterior limb of the anterior commissure (IPAC). J Chem Neuroanat 2002 0.78
74 Expression of constitutively active p21H-rasval12 in postmitotic pyramidal neurons results in increased dendritic size and complexity. J Comp Neurol 2003 0.78
75 Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J Chem Neuroanat 2005 0.78
76 Morphometry of the amygdala in patients with questionable dementia and mild dementia. J Neurol Sci 2005 0.78
77 Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins--implications for Alzheimer's disease. Neurobiol Aging 2012 0.78
78 On the quantification of intracellular proteins in multifluorescence-labeled rat brain slices using slide-based cytometry. Cytometry A 2011 0.77
79 Vegetable stalk as a nidus for gallstone formation in a patient with a juxtapapillary duodenal diverticulum. Gastrointest Endosc 2002 0.77
80 Distribution and classification of aggrecan-based extracellular matrix in the thalamus of the rat. J Neurosci Res 2010 0.77
81 Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease. Neuropathol Appl Neurobiol 2014 0.77
82 PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation. J Neural Transm (Vienna) 2009 0.77
83 Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli. J Cell Mol Med 2007 0.76
84 Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna) 2008 0.76
85 Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol Neurobiol 2002 0.76
86 Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study. Nutr Neurosci 2013 0.76
87 RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo. J Drug Target 2012 0.76
88 Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease. Acta Neuropathol 2015 0.76
89 Deprivation-induced dendritic shrinkage might be oppositely affected by the expression of wild-type and mutated human amyloid precursor protein. J Neurosci Res 2009 0.76
90 Activation of Ras in neurons modifies synaptic vesicle docking and release. Neuroreport 2004 0.76
91 Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease. Int J Alzheimers Dis 2011 0.75
92 The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. Mol Neurobiol 2013 0.75
93 Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Neurobiol Aging 2005 0.75
94 Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain. Brain Res 2009 0.75
95 Detection of nitric oxide synthase (NOS) immunoreactive neurons in the human septal area: a matter of method? J Chem Neuroanat 2004 0.75
96 An inexpensive technique for dot blotting in a 96-well format. Anal Biochem 2009 0.75
97 The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease. J Autoimmun 2002 0.75
98 Constitutive expression of p21H-Ras(Val12) in neurons induces increased axonal size and dendritic microtubule density in vivo. J Neurosci Res 2003 0.75
99 [Galantamine, an acetylcholinesterase inhibitor with various actions]. Med Monatsschr Pharm 2004 0.75
100 Constitutively enhanced p21Ras activity amplifies dendritic remodeling of hippocampal neurons during physical activity. Int J Dev Neurosci 2009 0.75
101 Simultaneous detection of tau phospho-epitopes with haptenylated antibodies. Neuroreport 2006 0.75
102 Early clinical and molecular detection of Alzheimer's disease. Int J Alzheimers Dis 2011 0.75
103 Activity-induced dendrite and dendritic spine development in human amyloid precursor protein transgenic mice. Int J Dev Neurosci 2011 0.75